TET protein function in conversion of 5mC to 5hmC during cell cycle entry
TET protein function in conversion of 5mC to 5hmC during cell cycle entry
批准号:
BB/J016284/1
负责人:
Nicholas Thomas
金额:
$48.45万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Parts of the DNA of human cells known as genes are copied (the copy is called an mRNA) by a process known as transcription, also known as gene expression. The sequence of each mRNA provides the blueprint for an individual protein. Eeach mRNA is "read" by the cell to produce many copies of each protein that then alter what the cell can do in the body. We are studying a type of cell in the blood called a T cell that helps to fight infection and changing the mRNAs that are expressed in T cells affects how it does this. The DNA is in the nucleus of the cell and it is about 3 metres long. It is bound by proteins called histones. The histones wrap and twist the DNA to compact it 10,000-times so it fits into the middle of the cell, called the nucleus. The position of these histones also controls how genes are transcribed into mRNA. Some cells in the body, such as stem cells and T cells are in a resting state called quiescence. It is important to keep these cells quiescent until the body signals them to divide and become activated. We showed that there is a regulatory point, called the commitment point and T cells have to be stimulated past this control point in order to become committed to proliferate. When these quiescent cells are stimulated a large number of genes are induced, which is critical for ensuring that cell proliferation and activation occur correctly. We have evidence that a modification to the DNA, called 5hmC occurs when the T cells start to proliferate and we think this may occur because proteins called "TET" are induced. We know that the 5hmC modification determines whether some genes can be transcribed or not. This project will investigate our hypothesis that formation of 5hmC by TET as T cells start to proliferate is important in regulating the transcription of some genes. This is important as we believe that this will be a new mechanism that regulates a very important cell of our immune system.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/srep08540
发表时间:
2015-02-23
期刊:
Scientific reports
影响因子:
4.6
作者:
[Chung SS, Pandini A, Annibale A, Coolen AC, Thomas NS, Fraternali F]
通讯作者:
Fraternali F
Heritage Matters: Culture and Development in the Pacific
-
批准号:AH/P007538/1
-
项目类别:Research Grant
-
资助金额:$10.25万
-
财政年份:2016
-
负责人:Nicholas Thomas
-
依托单位:
Artefacts of Encounter: Cross-cultural exchange on early European voyages into Polynesia (1765-1840) and socio-cultural transformation
-
批准号:ES/G045968/1
-
项目类别:Research Grant
-
资助金额:$97.59万
-
财政年份:2010
-
负责人:Nicholas Thomas
-
依托单位:
Melanesian art: 0bjects, narratives and indigenous owners
-
批准号:19316/2
-
项目类别:Research Grant
-
资助金额:$38.65万
-
财政年份:2008
-
负责人:Nicholas Thomas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: